Allogene Therapeutics Excess Tax Benefit from Stock Compensation (Quarterly) Insights

Allogene Therapeutics, Inc. (ALLO)

2.78 +0.05 (+1.83%) USD | NASDAQ | Feb 27, 16:00

2.76 -0.02 (-0.72%) Pre-Market: 20:00

View Excess Tax Benefit from Stock Compensation (Quarterly) for ALLO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Excess Tax Benefit from Stock Compensation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks

Start Trial